We developed an immune‐related gene prognostic index (IGPI) associated with progression
and provided new insights into the tumour immune microenvironment (TIME) for prostate …

Accumulating evidences indicates that the immune landscape signature dramatically
correlates with tumorigenesis and prognosis of prostate cancer (PCa). Here, we identified a …

Prostate cancer (PCa) is one of the most common malignancies in male. We aim to establish
a novel gene signature for immune infiltration and outcome (biochemical recurrence (BCR) …

Background: Decision-making regarding biochemical recurrence (BCR) in localized prostate
cancer (PCa) patients after radical prostatectomy (RP) mainly relies on clinicopathological …

Background: The tumor microenvironment (TME) and immune checkpoint inhibitors have
been shown to promote active immune responses through different mechanisms. We …

A substantial proportion of prostatic adenocarcinoma (PRAD) patients experience
biochemical failure (BCF) after radical prostatectomy (RP). The immune microenvironment …

In this study, we established a novel immunologic gene prognostic index (IGPI) to predict
metastasis and provided new insights into tumor immune microenvironment (TIME) for PCa …

Background An increasing number of studies has indicated that the tumor microenvironment
(TME), an important component of tumor tissue, has clinicopathological significance in …

Background Prostate cancer (PCa) is an immune-responsive disease. The current study
sought to explore a robust immune-related prognostic gene signature for PCa. Methods …

Background The tumor microenvironment (TME) primarily comprises cancer cells, cancer-
infiltrating immune cells, and stromal cells. The tumor cells alter the TME by secreting …